Tim Piser, PhD2018-12-06T15:09:22+00:00

Tim Piser, PhD

Chief Scientific Officer

Tim Piser is the Chief Scientific Officer at Cadent and has passionately pursued the discovery and development of neuroscience therapeutics for almost two decades in big pharma and in biotech, most notably at AstraZeneca and FORUM Pharmaceuticals. There, he led neuropharmacology teams and both NMDA and nicotinic receptor drug discovery projects and product development teams from lead optimization through Phase 2 trials. Tim leverages collaborative scientific insight and quantitative translational pharmacology to find innovative paths to discover and develop potential breakthrough medicines.

Tim earned his Ph.D. in pharmacology from the University of Minnesota.

Our Team

Tim Piser, PhD

Chief Scientific Officer

Tim Piser is the Chief Scientific Officer at Cadent and has passionately pursued the discovery and development of neuroscience therapeutics for almost two decades in big pharma and in biotech, most notably at AstraZeneca and FORUM Pharmaceuticals. There, he led neuropharmacology teams and both NMDA and nicotinic receptor drug discovery projects and product development teams from lead optimization through Phase 2 trials. Tim leverages collaborative scientific insight and quantitative translational pharmacology to find innovative paths to discover and develop potential breakthrough medicines.

Tim earned his Ph.D. in pharmacology from the University of Minnesota.

Our Team

Tim Piser, PhD

Chief Scientific Officer

Tim Piser is the Chief Scientific Officer at Cadent and has passionately pursued the discovery and development of neuroscience therapeutics for almost two decades in big pharma and in biotech, most notably at AstraZeneca and FORUM Pharmaceuticals. There, he led neuropharmacology teams and both NMDA and nicotinic receptor drug discovery projects and product development teams from lead optimization through Phase 2 trials. Tim leverages collaborative scientific insight and quantitative translational pharmacology to find innovative paths to discover and develop potential breakthrough medicines.

Tim earned his Ph.D. in pharmacology from the University of Minnesota.

Our Team